RXRX260116C00020000 Option on Recursion Pharmaceuticals

An 'Out of The Money' option on Recursion has a strike price that Recursion Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Recursion Pharmaceuticals' 'Out of The Money' options include buying the options if you expect a big move in Recursion Pharmaceuticals' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Recursion Pharmaceuticals' Option Greeks for the contract ending on 2026-01-16 at a strike price of 20.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Recursion Pharmaceuticals' option greeks, its implied volatility helps estimate the risk of Recursion Pharmaceuticals stock implied by the prices of the options on Recursion Pharmaceuticals' stock.

Put options written on Recursion Pharmaceuticals grant holders of the option the right to sell a specified amount of Recursion Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Recursion Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Recursion Pharmaceuticals is like buying insurance aginst Recursion Pharmaceuticals' downside shift.

By selling Recursion Pharmaceuticals' put option, the investors signal their bearish sentiment. A short position in a put option written on Recursion Pharmaceuticals will generally make money when the underlying price is above the strike price. Therefore Recursion Pharmaceuticals' put payoff at expiration depends on where the Recursion Stock price is relative to the put option strike price. The breakeven price of 20.2 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Recursion Pharmaceuticals' price. Finally, at the strike price of 20.0, the payoff chart is constant and positive.

Recursion Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Recursion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Recursion. It also shows strike prices and maturity days for a Recursion Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.